Volume 8, Issue 1

New Focus on Colorectal Cancer in CF

In this issue:

With respiratory failure from CF lung disease becoming less common as a cause of death, clinical attention is now focusing on identifying and managing other causes of morbidity and mortality among patients with CF. One of the most prominent is colorectal cancer (CRC), with a growing body of evidence showing an increased incidence in patients with cystic fibrosis after lung transplantation. 

In this issue, Dr. Denis Hadjiliadis from the Perelman School of Medicine at the University of Pennsylvania reviews the recent literature describing the magnitude of the increased risk of CRC in patients with CF, possible mechanisms for CRC development, and the new 2018 consensus screening recommendations.

Learning objectives:

  • Summarize the new guidelines for colorectal cancer screening in patients with CF.

  • Describe potential problems with implementing the new CF colorectal cancer screening guidelines.

  • Identify patients with CF who can most benefit from screening for colorectal cancer.


Denis Hadjiliadis, MD
Denis Hadjiliadis, MD

Paul F Harron, Jr. Associate Professor of Medicine
Division of Pulmonary, Allergy and Critical Care
Program Director, Adult Cystic Fibrosis Center
Perelman School of Medicine, University of Pennsylvania

Program Directors:

Peter J. Mogayzel, Jr., MD, PhD

Professor of Pediatrics
Director, Cystic Fibrosis Center
Johns Hopkins University School of Medicine
Baltimore, MD

Noah Lechtzin, MD, MHA

Director, Adult Cystic Fibrosis Program
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD

Suzanne Sullivan, RN, BSN

Senior Clinical Nurse
The Johns Hopkins University
Baltimore, MD

Length of activity:

1.0 hour Physicians
1.0 contact hour Nurses

Launch date: September 28, 2018
Expiration date: September 27, 2020